AstraZeneca in Talks With Bristol Myers Squibb on Potential $400 Billion Pharma Megadeal
AstraZeneca in Talks With Bristol Myers Squibb on Potential $400 Billion Pharma Megadeal British pharmaceutical giant AstraZeneca has held preliminary discussions with U.S. rival Bristol Myers Squibb about a potential merger that would create one of the largest pharmaceutical companies in the world, with a combined value approaching $400 billion, according to a Financial Times … Read more
